Company: SHPH
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001641172-25-009325
Chunk: 19

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-05-08
Form: 10-Q
Item: Item 3
Chunk 19
---
 the information required by this item.

ITEM 2. UNREGISTERED SALES OF SECURITIES AND USE
OF PROCEEDS

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

Not Applicable.

ITEM 4. MINE SAFETY DISCLOSURES

Not Applicable.

ITEM 5. OTHER INFORMATION

During the quarter ended March 31, 2025, none of our
directors or executive officers adopted or terminated any “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading
arrangement” (as each item is defined Item 408(a) of Regulation S-K).

Item 6.
Exhibits

The following exhibits are filed or furnished with
this report:

    Exhibit No.
     
    Description of Exhibit
  
    10.1
     
    Form of Pre-Funded Warrants (incorporated by reference to Exhibit 4.9 to the Registration Statement on Form S-1/A (File No. 333-284889) filed on March 5, 2025).
  
    10.2
     
    Amendment Agreement, dated February 26, 2025, between Shuttle Pharmaceuticals Holdings, Inc. and Alto Opportunity Master Fund, SPC – Segregated Master Portfolio B (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed February 27, 2025).
  
    10.3
     
    Revolving Loan Agreement, dated February 28, 2025, between Shuttle Pharmaceuticals Holdings, Inc. and Bowery Consulting Group Inc. (incorporated by reference to the Current Report on Form 8-K filed on February 28, 2025).
  
    10.4
     
    Revolving Note, dated February 28, 2025, between Shuttle Pharmaceuticals Holdings, Inc. and Bowery Consulting Group Inc. (incorporated by reference to Current Report on Form 8-K filed on February 28, 2025).
  
    10.5
     
    Employment Agreement, dated March 11, 2025, between Shuttle Pharmaceuticals Holdings, Inc. and Christopher Cooper (incorporated by reference to Exhibit 10. 1 to the Current Report on Form 8-K filed on March 12, 2025).
  
    10.6
     
    Form of Employment Agreement, dated March 31,